Cargando…
Perspectives on the Role of Isoliquiritigenin in Cancer
SIMPLE SUMMARY: Isoliquiritigenin (ISL), a natural bioactive compound with a chalcone structure, demonstrates high antitumor efficacy. This review presents a summary of the latest research on the metabolites, pharmakinetics, and pharmacological effects of ISL and its derivatives. We highlighted the...
Autores principales: | Wang, Kai-Lee, Yu, Ying-Chun, Hsia, Shih-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795842/ https://www.ncbi.nlm.nih.gov/pubmed/33401375 http://dx.doi.org/10.3390/cancers13010115 |
Ejemplares similares
-
Isoliquiritigenin induces apoptosis and autophagy and inhibits endometrial cancer growth in mice
por: Wu, Chi-Hao, et al.
Publicado: (2016) -
Isoliquiritigenin Induces Autophagy and Inhibits Ovarian Cancer Cell Growth
por: Chen, Hsin-Yuan, et al.
Publicado: (2017) -
Isoliquiritigenin Reverses Epithelial-Mesenchymal Transition Through Modulation of the TGF-β/Smad Signaling Pathway in Endometrial Cancer
por: Chen, Hsin-Yuan, et al.
Publicado: (2021) -
Effects of isoliquiritigenin on ovarian cancer cells
por: Li, Nan, et al.
Publicado: (2018) -
Isoliquiritigenin Suppresses E2-Induced Uterine Leiomyoma Growth through the Modulation of Cell Death Program and the Repression of ECM Accumulation
por: Lin, Po-Han, et al.
Publicado: (2019)